Pluristem Therapeutics Inc.
PSTI · NASDAQ
6/30/2025 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
|---|---|---|---|---|
| Revenue | $1,336 | $0 | $23 | $54 |
| % Growth | – | -100% | -57.4% | – |
| Cost of Goods Sold | $682 | $0 | $0 | $2 |
| Gross Profit | $654 | $0 | $23 | $52 |
| % Margin | 49% | – | 100% | 96.3% |
| R&D Expenses | $14,004 | $30,066 | $21,577 | $26,427 |
| G&A Expenses | $9,979 | $20,557 | $7,922 | $9,157 |
| SG&A Expenses | $9,979 | $20,557 | $7,922 | $9,157 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $23,983 | $50,623 | $29,499 | $35,584 |
| Operating Income | -$23,329 | -$50,623 | -$29,476 | -$35,532 |
| % Margin | -1,746.2% | – | -128,156.5% | -65,800% |
| Other Income/Exp. Net | $79 | $758 | $324 | $225 |
| Pre-Tax Income | -$23,250 | -$49,865 | -$29,152 | -$35,307 |
| Tax Expense | $0 | $0 | $0 | $225 |
| Net Income | -$23,250 | -$49,865 | -$29,152 | -$35,307 |
| % Margin | -1,740.3% | – | -126,747.8% | -65,383.3% |
| EPS | -3.56 | -1.77 | -1.6 | -2.86 |
| % Growth | -101.1% | -10.6% | 44.1% | – |
| EPS Diluted | -3.56 | -1.77 | -1.6 | -2.86 |
| Weighted Avg Shares Out | 63,370 | 28,114 | 18,197 | 12,333 |
| Weighted Avg Shares Out Dil | 63,370 | 28,114 | 18,197 | 12,333 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $492 | $384 | $385 |
| Interest Expense | $873 | $78 | $196 | $0 |
| Depreciation & Amortization | $0 | $1,370 | $1,570 | $1,962 |
| EBITDA | -$23,329 | -$48,417 | -$27,386 | -$33,570 |
| % Margin | -1,746.2% | – | -119,069.6% | -62,166.7% |